Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard A. Paulson currently holds 198,331 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard A. Paulson has been a net seller of KPTI stock. They have purchased $0 and sold $647.3K worth of shares.
Richard A. Paulson's most recent insider trade was on Oct 15, 2025, when they sold 114,285 shares at $0.00 per share.
Richard A. Paulson serves as Executive at Karyopharm Therapeutics Inc. (KPTI). They have executed 45 insider transactions totaling $647.3K over their tenure at the company.
Richard A. Paulson holds the position of Executive at Karyopharm Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Richard A. Paulson has shown a selling trading pattern, with $0 in total purchases and $647.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Richard A. Paulson was on May 4, 2022, when they sold $173.6K worth of KPTI shares. This transaction involved 27,869 shares at $6.23 per share.
Richard A. Paulson currently owns 198,331 shares of Karyopharm Therapeutics Inc. (KPTI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard A. Paulson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard A. Paulson has 45 Form 4 filings on record as an insider at Karyopharm Therapeutics Inc..
Set alerts for Richard A. Paulson and 40,000+ other insiders.